Your browser doesn't support javascript.
loading
Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.
Li, Hongzhi; Yuan, Weihua; Bin, Shufang; Wu, Guang; Li, Panyuan; Liu, Min; Yang, Jifeng; Li, Xiang; Yang, Kaiyan; Gu, Haihua.
Afiliação
  • Li H; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
  • Yuan W; Department of Clinical Laboratory, The Children's Hospital, Zhejiang University School of Medicine Hangzhou 310052, Zhejiang, China.
  • Bin S; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
  • Wu G; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
  • Li P; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
  • Liu M; Department of Orthopedics, Third Affiliated Hospital of Wenzhou Medical University Wenzhou 325200, Zhejiang, China.
  • Yang J; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
  • Li X; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
  • Yang K; Department of Pathology, First Affiliated Hospital of Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
  • Gu H; Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Am J Cancer Res ; 12(6): 2891-2892, 2022.
Article em En | MEDLINE | ID: mdl-35812051

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China